Xenon Pharmaceuticals (XENE) Short Interest Ratio & Short Volume → Trump is sounding the alarm (From Preserve Gold) (Ad) Free XENE Stock Alerts $40.10 +0.60 (+1.52%) (As of 04/25/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Xenon Pharmaceuticals Short Interest DataCurrent Short Volume2,620,000 sharesPrevious Short Volume2,760,000 sharesChange Vs. Previous Month-5.07%Dollar Volume Sold Short$108.23 millionShort Interest Ratio / Days to Cover7.3Last Record DateApril 15, 2024Outstanding Shares75,430,000 sharesPercentage of Shares Shorted3.47%Today's Trading Volume255,970 sharesAverage Trading Volume305,312 sharesToday's Volume Vs. Average84% Short Selling Xenon Pharmaceuticals ? Sign up to receive the latest short interest report for Xenon Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatXENE Short Interest Over TimeXENE Days to Cover Over TimeXENE Percentage of Float Shorted Over Time Ad Preserve GoldTrump is sounding the alarmEurope is one of the latest to release a central bank digital currency and along with it, new cash rules. Christine Lagarde, President of the European Central Bank, shared "Now we have in Europe this threshold, above 1,000 euros you cannot pay cash… if you get caught you are fined or you are going to jail". Are you prepared?Click here to get your complimentary retirement guide! Xenon Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/20242,620,000 shares $108.23 million -5.1%N/A7.3 $41.31 3/31/20242,760,000 shares $118.82 million +5.3%N/A7 $43.05 3/15/20242,620,000 shares $115.18 million -3.0%N/A5.7 $43.96 2/29/20242,700,000 shares $127.44 million +6.7%N/A5.3 $47.20 2/15/20242,530,000 shares $123.19 million -10.0%N/A4.2 $48.69 1/31/20242,810,000 shares $127.07 million +12.0%N/A4.2 $45.22 Get the Latest News and Ratings for XENE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Xenon Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 1/15/20242,510,000 shares $113.18 million +13.1%N/A3.6 $45.09 12/31/20232,220,000 shares $102.25 million -5.9%N/A3.3 $46.06 12/15/20232,360,000 shares $97.73 million +20.4%N/A3.6 $41.41 11/30/20231,960,000 shares $71.70 million +14.6%N/A3.3 $36.58 11/15/20231,710,000 shares $49.85 million -2.8%N/A3.4 $29.15 10/31/20231,760,000 shares $54.56 million -10.2%N/A4.2 $31.00 10/15/20231,960,000 shares $68.87 million -26.3%N/A5.2 $35.14 9/30/20232,660,000 shares $90.87 million -4.0%N/A7.2 $34.16 9/15/20232,770,000 shares $102.10 million -0.4%N/A8.6 $36.86 8/31/20232,780,000 shares $108.36 million +2.2%N/A8.5 $38.98 8/15/20232,720,000 shares $101.62 million +2.6%N/A7.8 $37.36 7/31/20232,650,000 shares $97.84 million -4.3%N/A7.8 $36.92 7/15/20232,770,000 shares $107.61 million -10.9%N/A7.7 $38.85 6/30/20233,110,000 shares $119.74 million -2.8%N/A8.6 $38.50 6/15/20233,200,000 shares $134.50 million +9.6%N/A8.3 $42.03 5/31/20232,920,000 shares $112.51 million -3.6%N/A7.5 $38.53 5/15/20233,030,000 shares $126.47 million -12.2%N/A7.5 $41.74 4/30/20233,450,000 shares $138.97 million -1.2%N/A8.5 $40.28 4/15/20233,490,000 shares $124.24 million -11.4%N/A9 $35.60 3/31/20233,940,000 shares $141.01 million +7.7%N/A9.8 $35.79 3/15/20233,660,000 shares $124.37 million +16.2%N/A9.3 $33.98 2/28/20233,150,000 shares $124.30 million +2.9%N/A8.1 $39.46 2/15/20233,060,000 shares $118.76 million +1.0%N/A8.3 $38.81 1/31/20233,030,000 shares $118.44 million -16.5%N/A8 $39.09 1/15/20233,630,000 shares $131.41 million +1.4%N/A9.5 $36.20 12/30/20223,580,000 shares $141.16 million -6.3%N/A9.6 $39.43 12/15/20223,820,000 shares $145.81 million +2.4%N/A10.4 $38.17 11/30/20223,730,000 shares $137.56 million +1.4%N/A10.7 $36.88 11/15/20223,680,000 shares $128.03 million +4.8%N/A10.3 $34.79 10/31/20223,510,000 shares $128.36 million +9.0%N/A9 $36.57 10/15/20223,220,000 shares $111.64 million +15.8%N/A8.2 $34.67 9/30/20222,780,000 shares $100.36 million +7.3%N/A6.9 $36.10 9/15/20222,590,000 shares $101.79 million +9.8%N/A5.9 $39.30 8/31/20222,360,000 shares $91.59 million +28.3%N/A4.6 $38.81Trump is sounding the alarm (Ad)Europe is one of the latest to release a central bank digital currency and along with it, new cash rules. Christine Lagarde, President of the European Central Bank, shared "Now we have in Europe this threshold, above 1,000 euros you cannot pay cash… if you get caught you are fined or you are going to jail". Are you prepared?Click here to get your complimentary retirement guide! XENE Short Interest - Frequently Asked Questions What is Xenon Pharmaceuticals' current short interest? Short interest is the volume of Xenon Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of April 15th, traders have sold 2,620,000 shares of XENE short. Learn More on Xenon Pharmaceuticals' current short interest. What is a good short interest ratio for Xenon Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. XENE shares currently have a short interest ratio of 7.0. Learn More on Xenon Pharmaceuticals's short interest ratio. Which institutional investors are shorting Xenon Pharmaceuticals? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Xenon Pharmaceuticals: Concourse Financial Group Securities Inc., and Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Xenon Pharmaceuticals' short interest increasing or decreasing? Xenon Pharmaceuticals saw a decrease in short interest during the month of April. As of April 15th, there was short interest totaling 2,620,000 shares, a decrease of 5.1% from the previous total of 2,760,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Xenon Pharmaceuticals' short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to Xenon Pharmaceuticals: Bausch Health Companies Inc. (5.81%), Crinetics Pharmaceuticals, Inc. (7.50%), Amicus Therapeutics, Inc. (10.60%), HUTCHMED (China) Limited (0.30%), Arrowhead Pharmaceuticals, Inc. (7.16%), Biohaven Ltd. (10.10%), IDEAYA Biosciences, Inc. (14.86%), MoonLake Immunotherapeutics (15.38%), ACADIA Pharmaceuticals Inc. (6.77%), Axsome Therapeutics, Inc. (16.36%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Xenon Pharmaceuticals stock? Short selling XENE is an investing strategy that aims to generate trading profit from Xenon Pharmaceuticals as its price is falling. XENE shares are trading up $0.60 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Xenon Pharmaceuticals? A short squeeze for Xenon Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of XENE, which in turn drives the price of the stock up even further. How often is Xenon Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including XENE, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: BHC Short Interest Data CRNX Short Interest Data FOLD Short Interest Data HCM Short Interest Data ARWR Short Interest Data BHVN Short Interest Data IDYA Short Interest Data MLTX Short Interest Data ACAD Short Interest Data AXSM Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:XENE) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsTrump is sounding the alarmPreserve GoldBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressFed launches fourth dollar overhaulStansberry Research